CaƱete, Baby Girl .

HRN: 27-72-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2025
AMPICILLIN 1GM (VIAL)
09/07/2025
09/13/2025
IV
145mg
Q12 Hours
NAMF (PROM)
Checking Initial Appropriateness 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines